The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Regional · North America

Coverage in the US: a map of the usual obstacles

GP
g.pemberton_ukTL3Regional · UK9 Oct 2025#1

Coverage in the US: a map of the usual obstacles — setting out what I have, and where I think it stops being reliable.

Trying to establish the boundary conditions on coverage. The general claim is fine; I want to know where it stops holding, because that is where I am operating.

Three edge cases below, in increasing order of how far outside the usual range they sit.

17 likes 10mo
MY
m.yilmazTL215 Oct 2025#2

Speaking only to coverage as I have actually seen it, rather than as it is usually described: the effect is real, it is smaller than the thread suggests, and the variance between people is larger than the effect.

2 likes 9mo
AS
a.salcedoTL3Regular20 Oct 2025#3

Cross-border purchasing raises both a legal question and a practical one, and the legal one is yours to establish for your own jurisdiction.

0 likes 9mo
KH
ka.haddadTL224 Oct 2025#4

What would change my mind on coverage is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would rather say so than pretend to more.

28 likes 9mo
FA
f.abrahamsenTL2Member27 Oct 2025#5
m.yilmaz, post #2: Speaking only to coverage as I have actually seen it, rather than as it is usually described: the effect is real, it is smaller than the thread suggests, and the variance between people is larger than the effect. Go to post

United States: FDA licenses compounds. Prescribing and pharmacy practice are state-regulated. Compounds are prescription-only. Coverage is decided by individual plans, not nationally.

Worth checking against a second source before it gets quoted onward.

14 likes in reply to #2 9mo
EC
e.coelhoTL231 Oct 2025#6
g.pemberton_uk, post #1: Coverage in the US: a map of the usual obstacles — setting out what I have, and where I think it stops being reliable. Trying to establish the boundary conditions on coverage. The general claim is fine; I want to know where it stops holding, because that is where I am operating. Three edge cases below, in increasing order of how far… Go to post

Cost comparisons should state whether they include the device and the dispensing fee, because those differ between routes and between states.

5 likes in reply to #1 9mo
GH
g.haalandTL3Regular3 Nov 2025 · edited#7

On coverage, the part that usually goes wrong is that the question is asked as though it has one answer. It has a range, and the width of the range is the interesting bit.

If you can post the two or three numbers you are working from, several people here will check the arithmetic rather than argue about the conclusion.

0 likes 9mo
ID
il.dumitruTL26 Nov 2025#8
O
OkaforTL3Regular9 Nov 2025#9

No disagreement from me. Posting only so the question does not look ignored.

2 likes 9mo
IO
i.oseiTL212 Nov 2025#10
ka.haddad, post #4: What would change my mind on coverage is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would rather say so than pretend to more. Go to post

Appeals succeed more often than people expect when they answer the stated criterion point by point and include nothing else.

0 likes in reply to #4 8mo
JI
j.iyerTL215 Nov 2025#11
ka.haddad, post #4: What would change my mind on coverage is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would rather say so than pretend to more. Go to post

Adding the measurement that post #10 says would settle it.

Nobody has said the unglamorous part of coverage yet, so: most of the variation is explained by things that are boring to write about and easy to check.

0 likes in reply to #4 8mo
B
batchlogTL3Regular18 Nov 2025#12
g.haaland, post #7: On coverage, the part that usually goes wrong is that the question is asked as though it has one answer. It has a range, and the width of the range is the interesting bit. If you can post the two or three numbers you are working from, several people here will check the arithmetic rather than argue about the conclusion. Go to post

My experience of coverage contradicts the reply above. I am posting it as a data point rather than as a refutation, because one person's experience is exactly that.

0 likes in reply to #7 8mo
IA
id.almeidaTL220 Nov 2025#13

Prior authorisation, step therapy, and exclusion of weight-management indications from coverage are common access barriers. The denial letter tells you which barrier you are facing.

The interesting part of this is the exception, and I do not understand the exception.

4 likes 8mo
BV
bias_varianceTL4Biostatistician23 Nov 2025#14

Answering the coverage question as asked, then the question I think is meant. As asked: yes, with the qualification below. As meant: it depends on how the first measurement was taken.

13 likes 8mo
GR
g.radichTL226 Nov 2025#15
ka.haddad, post #4: What would change my mind on coverage is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would rather say so than pretend to more. Go to post

The arithmetic in post #12 is right; the assumption feeding it is the part to check.

Coverage is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out properly. Worth twenty minutes before adding to this one.

0 likes in reply to #4 8mo
MM
maintenance_modeTL3Regular28 Nov 2025#16

Answering the question post #14 raises rather than the one it answers.

Anyone reporting an outcome should give the stated reason rather than the verdict. The reason is the part somebody else can use.

2 likes 8mo
SK
s.kuuselaTL21 Dec 2025#17

What I would want before treating coverage as settled: the method, the sample, and whether anyone tried to find the opposite result. Two of the three are usually missing.

8 likes 8mo
TY
two_year_lineTL3Regular3 Dec 2025 · edited#18

Provincial formularies in Canada are published and are the correct source for coverage information. Coverage for weight management is less common than for diabetes.

It is one reading of the data and not the only reasonable one.

19 likes 8mo
FK
f.kimaniTL26 Dec 2025#19
j.iyer, post #11: Adding the measurement that post #10 says would settle it. Nobody has said the unglamorous part of coverage yet, so: most of the variation is explained by things that are boring to write about and easy to check. Go to post

The confident answers on coverage and the well-sourced answers are not the same answers, which is the most useful thing I have learned reading this category.

20 likes in reply to #11 8mo
K
KLindqvistTL4 Moderator8 Dec 2025#20

Coverage decisions are made by individual payers and vary within the same jurisdiction. A denial from one says nothing about another.

It is worth stating the boring hypothesis before the interesting one.

0 likes 8mo
K
KTurkingtonTL3Regular11 Dec 2025#21
a.salcedo, post #3: Cross-border purchasing raises both a legal question and a practical one, and the legal one is yours to establish for your own jurisdiction. Go to post

Answering the question post #19 raises rather than the one it answers.

Canada: Health Canada licenses compounds. Prescribing is provincial. Compounds are prescription-only. Coverage varies between public and private insurance.

5 likes in reply to #3 8mo
FN
f.novakTL213 Dec 2025#22

My position on coverage is current rather than settled. I have revised it once already and I expect to again, so treat it accordingly.

1 like 7mo
TI
trough_indexTL3Regular16 Dec 2025#23

Second this, and I would have said it less carefully.

30 likes 7mo
AN
a.norgaardTL218 Dec 2025#24

Post #22 is the version of this I will quote in future. One addition.

A note on how coverage gets discussed rather than on coverage itself: the confident posts get the replies and the careful ones get ignored, and the careful ones have been right more often.

15 likes 7mo
BR
buffer_reviewTL3Regular20 Dec 2025#25
g.pemberton_uk, post #1: Coverage in the US: a map of the usual obstacles — setting out what I have, and where I think it stops being reliable. Trying to establish the boundary conditions on coverage. The general claim is fine; I want to know where it stops holding, because that is where I am operating. Three edge cases below, in increasing order of how far… Go to post

Answering the question post #24 raises rather than the one it answers.

Date every claim in this subcategory. Positions here have moved repeatedly and old posts are read as current.

3 likes in reply to #1 7mo
AC
a.cardosoTL223 Dec 2025#26

The arithmetic in post #24 is right; the assumption feeding it is the part to check.

I read the earlier replies on coverage twice before writing this, because I had assumed the opposite and wanted to be sure I was disagreeing with what was said rather than what I expected.

0 likes 7mo
L
LJankowiakTL3Regular25 Dec 2025#27

The honest answer on coverage is that it depends, and the useful part is the list of what it depends on. Four items, in rough order of how much they matter.

Most people get the first two right and then argue about the fourth.

22 likes 7mo
MA
mi.amankwahTL227 Dec 2025#28

Nothing in this subcategory is medical or legal advice, and the clinicians posting here say so on their own account.

Old habit: I write down the expected answer before I calculate it.

10 likes 7mo
MB
m.brobergTL230 Dec 2025#29

Reframing coverage slightly, because I think the disagreement is about the question rather than the answer. If the question is "does it happen", yes. If it is "how often", nobody here knows.

1 like 7mo
AR
a.reyesTL4 Admin1 Jan 2026#30
KTurkington, post #21: Answering the question post #19 raises rather than the one it answers. Canada: Health Canada licenses compounds. Prescribing is provincial. Compounds are prescription-only. Coverage varies between public and private insurance. Go to post

Say which country and which state or province. Regulatory position, availability and practical route can all differ within the same continent and frequently do.

0 likes in reply to #21 7mo